PROGENRA INC has a total of 21 patent applications. Its first patent ever was published in 2005. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Canada. Its main competitors in its focus markets biotechnology, measurement and pharmaceuticals are LISANTI MICHAEL P, NEN LIFE SCIENCE PROD INC and CEMM FORSCHUNGSZENTRUM FUER MOLEKULARE MEDIZIN GMBH.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 7 | |
#2 | WIPO (World Intellectual Property Organization) | 5 | |
#3 | Canada | 2 | |
#4 | EPO (European Patent Office) | 2 | |
#5 | Israel | 2 | |
#6 | Australia | 1 | |
#7 | China | 1 | |
#8 | Republic of Korea | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Measurement | |
#3 | Pharmaceuticals | |
#4 | Organic fine chemistry | |
#5 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Measuring microorganism processes | |
#2 | Analysing materials | |
#3 | Heterocyclic compounds | |
#4 | Medical preparations | |
#5 | Microorganisms | |
#6 | Therapeutic chemical compounds | |
#7 | Enzymes |
# | Name | Total Patents |
---|---|---|
#1 | Kizhakkethil-George Suresh Kumar | 8 |
#2 | Butt Tauseef R | 6 |
#3 | Weinstock Joseph | 6 |
#4 | Nicholson Benjamin | 6 |
#5 | Bernal Alejandro | 5 |
#6 | Wu Jian | 5 |
#7 | Wang Feng | 5 |
#8 | Marblestone Jeffrey Gordon | 4 |
#9 | Leach Craig | 3 |
#10 | Eddins Michael | 3 |
Publication | Filing date | Title |
---|---|---|
WO2018160944A1 | Azole compounds as ubiquitin-specific protease usp7 inhibitors | |
WO2017023684A2 | Covalent irreversible inhibitors of usp7 as anti-cancer agents | |
US9717717B1 | Methods of treating cancer through the inhibition of USP7 and immune system modulation | |
US2013273027A1 | Mutant proteases and methods of use thereof | |
US2014309141A1 | Methods of Screening for Inhibitors of Enzymes | |
CA2731704A1 | Methods of identifying modulators of ubiquitin ligases | |
EP1792181A2 | Diagnostic and screening methods and kits associated with proteolytic activity |